Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Baseline Demographic, Clinical, Laboratory Characteristics, and Medications of Patients. Variable | Total (N = 1594) | PTH ≤ 82 (N = 1150) | PTH > 82 (N = 444) | p Value: Vitamin D, µg/L | 19 (13.1 to 27) | 20.3(14.3 to 28.0) | 15.6 (10.5 to 23.0) | <0.001
Source: Results table. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This retrospective, single-center cohort study was conducted at the Antalya Training and Research Hospital, Department of Cardiology.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Prognostic Value of Parathyroid Hormone in Heart Failure with Reduced Ejection Fraction
Cohort study · Journal of Clinical Medicine · 2026
Original publication title
Prognostic Value of Parathyroid Hormone in Heart Failure with Reduced Ejection Fraction
© 2026 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: Background/Objectives
Parathyroid hormone (PTH) has emerged as a novel biomarker in heart failure (HF), reflecting neurohormonal, renal, and metabolic dysregulation within the cardiorenal: mineral axis. However, its independent prognostic value and incremental contribution remain unclear when evaluated through formal nested structures Therefore, this study aimed to evaluate the association between PTH and all-cause mortality in patients with heart failure with reduced ejection fraction (HFrEF) and to determine whether PTH provides additional prognostic information beyond NT-proBNP.
Source: Background/ObjectivesAbstract: Results
During a median follow-up of 36 months, 525 deaths occurred. Elevated PTH levels were associated with worse survival outcomes. In multivariable Cox regression analysis, both LnPTH (HR: 1.233, p = 0.0147) and LnNT-proBNP (HR: 1.374, p < 0.0001) were independent predictors of mortality. Combined elevation of PTH and NT-proBNP identified patients at the highest risk. The addition of LnPTH to the baseline model significantly improved global model fit (χ2 = 4.242, p = 0.0394). Importantly, the prognostic value of LnPTH was significantly modified by age (Pinteraction = 0.026) and renal function (Pinteraction = 0.038), demonstrating independent predictive power specifically in patients aged < 65 years (HR: 1.402) and those with eGFR ≥ 60 mL/min/1.73 m2 (HR: 1.454), but not in older or advanced renal impairment strata.
Source: ResultsAbstract: Conclusions
PTH is independently associated with mortality in patients with HFrEF and provides incremental prognostic value beyond NT-proBNP by optimizing global model fit. These findings support its role as a complementary biomarker within a multimarker strategy for improved risk stratification of the cumulative metabolic and cardiovascular burden.
Source: ConclusionsAuthors’ abstract
Background/Objectives:
Parathyroid hormone (PTH) has emerged as a novel biomarker in heart failure (HF), reflecting neurohormonal, renal, and metabolic dysregulation within the cardiorenal: mineral axis. However, its independent prognostic value and incremental contribution remain unclear when evaluated through formal nested structures Therefore, this study aimed to evaluate the association between PTH and all-cause mortality in patients with heart failure with reduced ejection fraction (HFrEF) and to determine whether PTH provides additional prognostic information beyond NT-proBNP.
Methods:
In this retrospective cohort study, 1594 patients with HFrEF (LVEF ≤ 40%) were analyzed. Serum PTH and NT-proBNP levels were log-transformed and evaluated as predictors of all-cause mortality. Patients were stratified according to PTH levels, and survival analysis was performed. Incremental model fit was evaluated using nested likelihood ratio tests. Stratified multivariable Cox models and formal interaction tests were executed across predefined clinical strata (age, renal function, and heart failure etiology).
Results:
During a median follow-up of 36 months, 525 deaths occurred. Elevated PTH levels were associated with worse survival outcomes. In multivariable Cox regression analysis, both LnPTH (HR: 1.233, p = 0.0147) and LnNT-proBNP (HR: 1.374, p < 0.0001) were independent predictors of mortality. Combined elevation of PTH and NT-proBNP identified patients at the highest risk. The addition of LnPTH to the baseline model significantly improved global model fit (χ2 = 4.242, p = 0.0394). Importantly, the prognostic value of LnPTH was significantly modified by age (Pinteraction = 0.026) and renal function (Pinteraction = 0.038), demonstrating independent predictive power specifically in patients aged < 65 years (HR: 1.402) and those with eGFR ≥ 60 mL/min/1.73 m2 (HR: 1.454), but not in older or advanced renal impairment strata.
Conclusions:
PTH is independently associated with mortality in patients with HFrEF and provides incremental prognostic value beyond NT-proBNP by optimizing global model fit. These findings support its role as a complementary biomarker within a multimarker strategy for improved risk stratification of the cumulative metabolic and cardiovascular burden.
Publication and source details
Original title: Prognostic Value of Parathyroid Hormone in Heart Failure with Reduced Ejection Fraction
Ahmet Genç; Gülsüm Meral Yılmaz Öztekin; Şükriye Uslu; Rauf Avcı
Journal of Clinical Medicine · 2026
* Correspondence: ahmet.genc6@saglik.gov.tr© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding. The APC was funded by the authors themselves.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:15:36.154600+00:00
DOI: 10.3390/jcm15134859 · PMC13361963